Latest News about APLS
Recent news which mentions APLS
Why Are Apellis Pharmaceuticals Shares Falling Today?
November 04, 2022
From Benzinga
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
7 Analysts Have This to Say About Apellis Pharmaceuticals
October 18, 2022
Tickers
APLS
From Benzinga
From Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
From Benzinga
Investigator Says Apellis' Lead Product Shows 'First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth'
October 03, 2022
Tickers
APLS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Stifel Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know
September 08, 2022
Tickers
APLS
From Benzinga
Moderna To $165? Plus This Analyst Cuts PT On FedEx
September 08, 2022
From Benzinga
Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday
August 25, 2022
From Benzinga
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 24, 2022
From Benzinga
Apellis Shares Show Mixed Reaction After Positive 2 Years Data From Late-Stage Retinal Disorder Study
August 24, 2022
Tickers
APLS
From Benzinga
7 Cheap Biotech Stocks to Buy Now
August 03, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
HC Wainwright Initiates Coverage On Upcoming Complement Franchise Company Apellis Pharmaceuticals
July 19, 2022
Tickers
APLS
From Benzinga
Dow Surges 500 Points; Johnson & Johnson Lowers Guidance
July 19, 2022
From Benzinga
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday's Mid-Day Session
July 19, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Apellis Shares Climb As FDA Accepts Geographic Atrophy Candidate Submission Under Priority Review
July 19, 2022
Tickers
APLS
From Benzinga